Table 2 List of the 72 significantly changed proteins during controlled ovarian hyperstimulation, P < 0.01.
Protein name | Gene name | Fold change log2 | Adjusted P-value |
|---|---|---|---|
Down-regulated proteins | |||
Alpha-1-acid glycoprotein 1 | ORM1 | − 0.40 | < 0.0001 |
Apolipoprotein E | APOE | − 0.37 | < 0.0001 |
Haptoglobin; Haptoglobin alpha chain; Haptoglobin beta chain | HP | -0.36 | < 0.0001 |
Serum amyloid A-4 protein | SAA2–SAA4; SAA4 | − 0.35 | 0.0063 |
Ig lambda chain V–V region DEL | NA | − 0.34 | 0.0050 |
Coagulation factor V; Coagulation factor V heavy chain; Coagulation factor V light chain | F5 | − 0.33 | 0.0005 |
Proteoglycan 4; Proteoglycan 4 C-terminal part | PRG4 | − 0.30 | 0.0045 |
Tetranectin | CLEC3B | − 0.27 | < 0.0001 |
NA | IGKV1–17 | − 0.27 | < 0.0001 |
NA | IGLV3–9 | − 0.26 | 0.0087 |
C4b-binding protein alpha chain | C4BPA | − 0.25 | < 0.0001 |
Plasma protease C1 inhibitor | SERPING1 | − 0.25 | < 0.0001 |
Complement component C6 | C6 | − 0.23 | < 0.0001 |
Antithrombin-III | SERPINC1 | − 0.23 | < 0.0001 |
Glutathione peroxidase; Glutathione peroxidase 3 | GPX3 | − 0.22 | 0.0015 |
Carboxylic ester hydrolase; Cholinesterase | BCHE | − 0.21 | 0.0040 |
Alpha-1-acid glycoprotein 2 | ORM2 | − 0.20 | 0.0069 |
Vitamin K-dependent protein S | PROS1 | − 0.19 | < 0.0001 |
C4b-binding protein beta chain | C4BPB | − 0.19 | 0.0017 |
NA | IGLV1–44 | − 0.17 | 0.0006 |
Extracellular matrix protein 1 | ECM1 | − 0.17 | 0.0005 |
Immunoglobulin J chain | IGJ; JCHAIN | − 0.17 | < 0.0001 |
NA | IGHV3–72 | − 0.17 | 0.0004 |
Transthyretin | TTR | − 0.17 | < 0.0001 |
Ig lambda-2 chain C regions; Ig lambda-3 chain C regions | IGLC3; IGLC2 | − 0.16 | 0.0001 |
Apolipoprotein B-100; Apolipoprotein B-48 | APOB | − 0.16 | 0.0009 |
Gelsolin | GSN | − 0.15 | < 0.0001 |
Complement C1q subcomponent subunit B | C1QB | − 0.15 | 0.0007 |
Complement factor I; Complement factor I heavy chain; Complement factor I light chain | CFI | − 0.15 | < 0.0001 |
Apolipoprotein D | APOD | − 0.15 | 0.0015 |
Apolipoprotein C-I; Truncated apolipoprotein C-I | APOC1 | − 0.14 | 0.0038 |
Histidine-rich glycoprotein | HRG | − 0.14 | 0.0007 |
Monocyte differentiation antigen CD14; Monocyte differentiation antigen CD14, urinary form; Monocyte differentiation antigen CD14, membrane-bound form | CD14 | − 0.13 | 0.0013 |
N-Acetylmuramoyl-l-alanine amidase | PGLYRP2 | − 0.13 | 0.0006 |
Apolipoprotein A-II; Proapolipoprotein A-II; Truncated apolipoprotein A-II | APOA2 | − 0.12 | 0.0067 |
Alpha-2-antiplasmin | SERPINF2 | − 0.11 | < 0.0001 |
NA | IGKV3–11 | − 0.11 | 0.0036 |
Complement C1q subcomponent subunit A | C1QA | − 0.11 | 0.0097 |
Complement component C7 | C7 | − 0.11 | 0.0008 |
Ig gamma-1 chain C region | IGHG1 | − 0.11 | 0.0009 |
Complement component C8 gamma chain | C8G | − 0.10 | 0.0087 |
Alpha-1-antichymotrypsin; Alpha-1-antichymotrypsin His-Pro-less | SERPINA3 | − 0.10 | 0.0003 |
Complement C4-B; Complement C4 beta chain; Complement C4-B alpha chain; C4a anaphylatoxin; C4b-B; C4d-B; Complement C4 gamma chain | C4B | − 0.08 | 0.0012 |
Complement factor B; Complement factor B Ba fragment; Complement factor B Bb fragment | CFB | − 0.06 | 0.0081 |
Up-regulated proteins | |||
Inter-alpha-trypsin inhibitor heavy chain H4; 70 kDa inter-alpha-trypsin inhibitor heavy chain H4; 35 kDa inter-alpha-trypsin inhibitor heavy chain H4 | ITIH4 | 0.11 | 0.0002 |
Apolipoprotein A-I; Proapolipoprotein A-I; Truncated apolipoprotein A-I | APOA1 | 0.13 | 0.0002 |
Kininogen-1; Kininogen-1 heavy chain; T-kinin; Bradykinin; Lysyl-bradykinin; Kininogen-1 light chain; Low molecular weight growth-promoting factor | KNG1 | 0.14 | 0.0008 |
Fibulin-1 | FBLN1 | 0.17 | 0.0018 |
Fibrinogen gamma chain | FGG | 0.17 | < 0.0001 |
Alpha-2-HS-glycoprotein; Alpha-2-HS-glycoprotein chain A; Alpha-2-HS-glycoprotein chain B | AHSG | 0.21 | < 0.0001 |
Fibrinogen alpha chain; Fibrinopeptide A; Fibrinogen alpha chain | FGA | 0.23 | < 0.0001 |
Fibrinogen beta chain; Fibrinopeptide B; Fibrinogen beta chain | FGB | 0.23 | < 0.0001 |
Alpha-1-antitrypsin; Short peptide from AAT | SERPINA1 | 0.27 | < 0.0001 |
Thyroxine-binding globulin | SERPINA7 | 0.27 | < 0.0001 |
Vitamin D-binding protein | GC | 0.27 | < 0.0001 |
Hyaluronan-binding protein 2; Hyaluronan-binding protein 2 50 kDa heavy chain;Hyaluronan-binding protein 2 50 kDa heavy chain alternate form; Hyaluronan-binding protein 2 27 kDa light chain; Hyaluronan-binding protein 2 27 kDa light chain alternate form | HABP2 | 0.28 | < 0.0001 |
Ceruloplasmin | CP | 0.29 | < 0.0001 |
von Willebrand factor; von Willebrand antigen 2 | VWF | 0.33 | 0.0002 |
Vitronectin; Vitronectin V65 subunit; Vitronectin V10 subunit; Somatomedin-B | VTN | 0.39 | < 0.0001 |
Corticosteroid-binding globulin | SERPINA6 | 0.42 | < 0.0001 |
NA | NA | 0.55 | 0.0007 |
Lipopolysaccharide-binding protein | LBP | 0.63 | < 0.0001 |
Fetuin-B | FETUB | 0.67 | < 0.0001 |
Actin, cytoplasmic 1;Actin, cytoplasmic 1, N-terminally processed | ACTB | 0.91 | 0.0031 |
Angiotensinogen;Angiotensin-1;Angiotensin-2;Angiotensin-3;Angiotensin-4;Angiotensin 1–9;Angiotensin 1–7;Angiotensin 1–5;Angiotensin 1–4 | AGT | 1.12 | < 0.0001 |
Sex hormone-binding globulin | SHBG | 1.54 | < 0.0001 |
Pregnancy zone protein | PZP | 1.83 | < 0.0001 |
Hemoglobin subunit beta;LVV-hemorphin-7;Spinorphin | HBB | 1.88 | < 0.0001 |
Hemoglobin subunit alpha | HBA1 | 1.89 | < 0.0001 |
Heat shock cognate 71 kDa protein | HSPA8 | 2.35 | 0.0063 |
78 kDa glucose-regulated protein | HSPA5 | 3.65 | 0.0027 |
Carbamoyl-phosphate synthase [ammonia], mitochondrial | CPS1 | 5.97 | < 0.0001 |